Janux Therapeutics Stock (NASDAQ:JANX), Quotes and News Summary

Q: What sector and industry does Janux Therapeutics (JANX) operate in?

Janux Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Janux Therapeutics Stock (NASDAQ: JANX) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 893.562K
Day Range	- - -
52 Wk Range	5.650 - 58.694
Market Cap	$2.525B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	66
Short Interest	15.52%
Days to Cover	8.64

Recent News

Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results.

Avi Kapoor

Why Is Cancer-Focused Janux Therapeutics Stock Trading Higher On Thursday?

Janux Therapeutics may be up for sale amid interest from major pharmaceutical firms. With shares quadrupling this year and a successful equity offering, Janux is making waves in the industry. The pharmaceutical industry has seen a surge in deal activities, with acquisitions totaling $27.8 billion since the year's start.

Vandana Singh

Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday

U.S. stocks were mixed, with the Dow Jones index falling over 50 points on Thursday. Shares of Enliven Therapeutics, Inc. (NASDAQ: ELVN) rose sharply during Thursday’s session.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Janux Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation ther...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Janux Therapeutics (JANX) stock?

You can purchase shares of Janux Therapeutics (NASDAQ: JANX) through any online brokerage.

View our list of the best stock brokerages.

Who are Janux Therapeutics's (JANX) competitors?

Other companies in Janux Therapeutics’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), MoonLake (NASDAQ:MLTX), SpringWorks Therapeutics (NASDAQ:SWTX), TG Therapeutics (NASDAQ:TGTX) and Arrowhead Pharma (NASDAQ:ARWR).

What is the target price for Janux Therapeutics (JANX) stock?

The latest price target for Janux Therapeutics (NASDAQ: JANX) was reported by JonesTrading on Tuesday, April 16, 2024. The analyst firm set a price target for 70.00 expecting JANX to rise to within 12 months (a possible 43.21% upside). 14 analyst firms have reported ratings in the last year.

Current Stock Price for Janux Therapeutics (JANX)?

The stock price for Janux Therapeutics (NASDAQ: JANX) is $48.88 last updated April 22, 2024 at 4:00 PM EDT.

Does Janux Therapeutics (JANX) pay a dividend?

There are no upcoming dividends for Janux Therapeutics.

When is Janux Therapeutics (NASDAQ:JANX) reporting earnings?

Janux Therapeutics’s Q1 earnings are confirmed for Tuesday, May 7, 2024.

Is Janux Therapeutics (JANX) going to split?

There is no upcoming split for Janux Therapeutics.

What sector and industry does Janux Therapeutics (JANX) operate in?

Janux Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-